Human papillomavirus infections

Epidemiology, pathogenesis, and therapy

Jessica Severson, Tanya Y. Evans, Patricia Lee, Teh Sheng Chan, Istvan Arany, Stephen K. Tyring

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Human papillomaviruses (HPV) are common human pathogens and are classified into more than 80 different types. These viruses produce benign warts in many cases and aggressive squamous cell carcinomas in other cases. Objective: The goal of this review is to update the reader on the epidemiology, pathogenesis, and therapy of HPV infections. Nonanogenital warts are transmitted by skin-to-skin contact while anogenital warts are usually transmitted sexually. Both types of warts produce much morbidity but rarely undergo malignant transformation. They are commonly treated with surgical or cytodestructive therapy, but immunomodulatory agents, such as imiquimod, have been proven to be very effective in anogenital warts and are being evaluated in nonanogenital warts. Other types of HPV have marked oncogenic potential such that over 99% of all cervical cancers and over 50% of other anogenital cancers are due to infection with oncogenic HPV. Many cofactors, such as cigarette smoking, genetics, and helper viruses, have potential roles in HPV oncogenesis, but their relative contributions are poorly understood. Other control measures for warts and HPV-associated cancers are under study, but the greatest future potential may be from the development of prophylactic and therapeutic vaccines. Conclusions: Infection with HPV is very prevalent as are the clinical manifestations of this family of pathogens. Improved therapies for warts (e.g., imiquimod) have recently become available. Vaccines for HPV offer hope for future interventions for warts as well as for prevention of anogenital malignancies.

Original languageEnglish (US)
Pages (from-to)43-60
Number of pages18
JournalJournal of Cutaneous Medicine and Surgery
Volume5
Issue number1
StatePublished - 2001

Fingerprint

Warts
Papillomavirus Infections
Epidemiology
imiquimod
Therapeutics
Hope
Helper Viruses
Papillomavirus Vaccines
Neoplasms
Skin
Immunomodulation
Infection
Uterine Cervical Neoplasms
Squamous Cell Carcinoma
Carcinogenesis
Vaccines
Smoking
Viruses
Morbidity

ASJC Scopus subject areas

  • Dermatology
  • Surgery

Cite this

Severson, J., Evans, T. Y., Lee, P., Chan, T. S., Arany, I., & Tyring, S. K. (2001). Human papillomavirus infections: Epidemiology, pathogenesis, and therapy. Journal of Cutaneous Medicine and Surgery, 5(1), 43-60.

Human papillomavirus infections : Epidemiology, pathogenesis, and therapy. / Severson, Jessica; Evans, Tanya Y.; Lee, Patricia; Chan, Teh Sheng; Arany, Istvan; Tyring, Stephen K.

In: Journal of Cutaneous Medicine and Surgery, Vol. 5, No. 1, 2001, p. 43-60.

Research output: Contribution to journalArticle

Severson, J, Evans, TY, Lee, P, Chan, TS, Arany, I & Tyring, SK 2001, 'Human papillomavirus infections: Epidemiology, pathogenesis, and therapy', Journal of Cutaneous Medicine and Surgery, vol. 5, no. 1, pp. 43-60.
Severson J, Evans TY, Lee P, Chan TS, Arany I, Tyring SK. Human papillomavirus infections: Epidemiology, pathogenesis, and therapy. Journal of Cutaneous Medicine and Surgery. 2001;5(1):43-60.
Severson, Jessica ; Evans, Tanya Y. ; Lee, Patricia ; Chan, Teh Sheng ; Arany, Istvan ; Tyring, Stephen K. / Human papillomavirus infections : Epidemiology, pathogenesis, and therapy. In: Journal of Cutaneous Medicine and Surgery. 2001 ; Vol. 5, No. 1. pp. 43-60.
@article{9e4edd0f7e7b492cbabf6de73d2a51d9,
title = "Human papillomavirus infections: Epidemiology, pathogenesis, and therapy",
abstract = "Background: Human papillomaviruses (HPV) are common human pathogens and are classified into more than 80 different types. These viruses produce benign warts in many cases and aggressive squamous cell carcinomas in other cases. Objective: The goal of this review is to update the reader on the epidemiology, pathogenesis, and therapy of HPV infections. Nonanogenital warts are transmitted by skin-to-skin contact while anogenital warts are usually transmitted sexually. Both types of warts produce much morbidity but rarely undergo malignant transformation. They are commonly treated with surgical or cytodestructive therapy, but immunomodulatory agents, such as imiquimod, have been proven to be very effective in anogenital warts and are being evaluated in nonanogenital warts. Other types of HPV have marked oncogenic potential such that over 99{\%} of all cervical cancers and over 50{\%} of other anogenital cancers are due to infection with oncogenic HPV. Many cofactors, such as cigarette smoking, genetics, and helper viruses, have potential roles in HPV oncogenesis, but their relative contributions are poorly understood. Other control measures for warts and HPV-associated cancers are under study, but the greatest future potential may be from the development of prophylactic and therapeutic vaccines. Conclusions: Infection with HPV is very prevalent as are the clinical manifestations of this family of pathogens. Improved therapies for warts (e.g., imiquimod) have recently become available. Vaccines for HPV offer hope for future interventions for warts as well as for prevention of anogenital malignancies.",
author = "Jessica Severson and Evans, {Tanya Y.} and Patricia Lee and Chan, {Teh Sheng} and Istvan Arany and Tyring, {Stephen K.}",
year = "2001",
language = "English (US)",
volume = "5",
pages = "43--60",
journal = "Journal of Cutaneous Medicine and Surgery",
issn = "1203-4754",
publisher = "Decker Publishing",
number = "1",

}

TY - JOUR

T1 - Human papillomavirus infections

T2 - Epidemiology, pathogenesis, and therapy

AU - Severson, Jessica

AU - Evans, Tanya Y.

AU - Lee, Patricia

AU - Chan, Teh Sheng

AU - Arany, Istvan

AU - Tyring, Stephen K.

PY - 2001

Y1 - 2001

N2 - Background: Human papillomaviruses (HPV) are common human pathogens and are classified into more than 80 different types. These viruses produce benign warts in many cases and aggressive squamous cell carcinomas in other cases. Objective: The goal of this review is to update the reader on the epidemiology, pathogenesis, and therapy of HPV infections. Nonanogenital warts are transmitted by skin-to-skin contact while anogenital warts are usually transmitted sexually. Both types of warts produce much morbidity but rarely undergo malignant transformation. They are commonly treated with surgical or cytodestructive therapy, but immunomodulatory agents, such as imiquimod, have been proven to be very effective in anogenital warts and are being evaluated in nonanogenital warts. Other types of HPV have marked oncogenic potential such that over 99% of all cervical cancers and over 50% of other anogenital cancers are due to infection with oncogenic HPV. Many cofactors, such as cigarette smoking, genetics, and helper viruses, have potential roles in HPV oncogenesis, but their relative contributions are poorly understood. Other control measures for warts and HPV-associated cancers are under study, but the greatest future potential may be from the development of prophylactic and therapeutic vaccines. Conclusions: Infection with HPV is very prevalent as are the clinical manifestations of this family of pathogens. Improved therapies for warts (e.g., imiquimod) have recently become available. Vaccines for HPV offer hope for future interventions for warts as well as for prevention of anogenital malignancies.

AB - Background: Human papillomaviruses (HPV) are common human pathogens and are classified into more than 80 different types. These viruses produce benign warts in many cases and aggressive squamous cell carcinomas in other cases. Objective: The goal of this review is to update the reader on the epidemiology, pathogenesis, and therapy of HPV infections. Nonanogenital warts are transmitted by skin-to-skin contact while anogenital warts are usually transmitted sexually. Both types of warts produce much morbidity but rarely undergo malignant transformation. They are commonly treated with surgical or cytodestructive therapy, but immunomodulatory agents, such as imiquimod, have been proven to be very effective in anogenital warts and are being evaluated in nonanogenital warts. Other types of HPV have marked oncogenic potential such that over 99% of all cervical cancers and over 50% of other anogenital cancers are due to infection with oncogenic HPV. Many cofactors, such as cigarette smoking, genetics, and helper viruses, have potential roles in HPV oncogenesis, but their relative contributions are poorly understood. Other control measures for warts and HPV-associated cancers are under study, but the greatest future potential may be from the development of prophylactic and therapeutic vaccines. Conclusions: Infection with HPV is very prevalent as are the clinical manifestations of this family of pathogens. Improved therapies for warts (e.g., imiquimod) have recently become available. Vaccines for HPV offer hope for future interventions for warts as well as for prevention of anogenital malignancies.

UR - http://www.scopus.com/inward/record.url?scp=0034948887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034948887&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 43

EP - 60

JO - Journal of Cutaneous Medicine and Surgery

JF - Journal of Cutaneous Medicine and Surgery

SN - 1203-4754

IS - 1

ER -